Prospective study of live attenuated vaccines for patients receiving immunosuppressive agents

Koichi Kamei(National Center For Child Health and Development), Shuichi Ito(Yokohama City University), Toshinao Kawai(National Center For Child Health and Development), Isao Miyairi(National Center For Child Health and Development), Katsuhiro Arai(National Center For Child Health and Development), Kenji Ishikura(Kitasato University), Kensuke Shoji(National Center For Child Health and Development), Reiko Ito(National Center For Child Health and Development), Masao Ogura(Hokkaido University Hospital)
PLoS ONE
October 1, 2020
10.1371/journal.pone.0240217
Cited by 15

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135